Europese Unie - Sloveens - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline panleucopenia virus (pli iv) - immunologicals za skupin felidae, - mačke - active immunisation of cats aged eight weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs. onset of immunity is one week after primary vaccination course the duration of immunity is one year after the primary vaccination course and three years after the last re-vaccination.

Europese Unie - Sloveens - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97) - immunologicals za skupin felidae, - mačke - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs ;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the feline leukaemia component, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Europese Unie - Sloveens - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated chlamydophila felis (905 strain), attenuated feline panleucopenia virus (pli iv) - immunologicals za skupin felidae, - mačke - active immunisation of cats aged eight weeks and older:• against feline viral rhinotracheitis to reduce clinical signs;• against calicivirus infection to reduce clinical signs;• against chlamydophila felis infection to reduce clinical signs;• against feline panleucopenia to prevent mortality and clinical signs. nastopi imunosti so dokazali en teden po primarno cepljenje seveda za rhinotracheitis, calicivirus, chlamydophila felis in panleucopenia komponente. the duration of immunity is one year after the last re-vaccination for the chlamydiosis component, and oneyear after primary vaccination and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Europese Unie - Sloveens - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97), attenuated chlamydophila felis (905 strain) - immunologicals za skupin felidae, - mačke - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against chlamydophila felis infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus, chlamydophila felis and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the chlamydiosis and feline leukaemia components, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Europese Unie - Sloveens - EMA (European Medicines Agency)

ceva-phylaxia co. ltd. - celični rekombinantni herpesvirus rekombinantnega herpesa (rhvt / nd), ki eksprimira fuzijski protein virusa bolezni atipične kokošje d-26 lentogeni sev - immunologicals za aves, Živo virusna cepiva - chicken; embryonated eggs - za aktivno imunizacijo dne 18. dan-stare embryonated kokošja jajca ali en dan starih piščancev za zmanjšanje umrljivosti in kliničnih znakov, ki jih povzroča virus atipične kokošje in zmanjšanje umrljivosti, klinični znaki in poškodb, ki jih povzročajo marek je bolezen, virus z fenotip "sovražno".

Europese Unie - Sloveens - EMA (European Medicines Agency)

zoetis belgium sa - udarci distemper virus, sev cdv bio 11/a, udarci adenovirus tipa 2, sev cav-2 bio 13, udarci parvovirus tip 2b, sev cpv-2b bio 12/b in udarci parainfluenza tipa 2 virus, sev cpiv-2 bio 15 (vse živo zmanjšan) - immunologicals za canidae, Živo virusna cepiva - psi - aktivna imunizacija psov od šestega tedna starosti. da bi preprečili umrljivosti in klinične znake, ki jih povzročajo udarci distemper virus,da se prepreči umrljivosti in klinične znake, ki jih povzročajo udarci adenovirus tipa 1), da preprečite klinični znaki in zmanjšanje virusne izločanje, povzročeno z udarci adenovirus tipa 2,da preprečuje klinične znake, levkopenija in virusnih izločanje, povzročeno z udarci parvovirus,da preprečuje klinične znake in zmanjšanje virusne izločanje, povzročeno z udarci parainfluenza virus.

Europese Unie - Sloveens - EMA (European Medicines Agency)

zoetis belgium sa - virusa parainfluence tipa 2, seva cpiv-2 bio 15 (živi oslabljen) - immunologicals za canidae, Živo virusna cepiva - psi - aktivna imunizacija psov po starosti šestih tednov, da se prepreči klinični znaki (nosni in očesni izcedek) in zmanjša izločanje virusa, ki ga povzroča virus parainfluence.

Europese Unie - Sloveens - EMA (European Medicines Agency)

zoetis belgium sa. - udarci parainfluenza tipa 2 virus, sev cpiv-2 bio 15 (v živo zmanjšan), leptospira interrogans serogroup australis serovar bratislava, sev, mslb 1088, l. interrogans serogroup icterohaemorrhagiae serovar icterohaemorrhagiae, sev, mslb 1089, l. interrogans serogroup canicola serovar canicola, sev, mslb 1090 in l. kirschneri serogroup grippotyphosa serovar grippotyphosa, sev, mslb 1091 (vse inaktivirano) - immunologicals za canidae, Živo virusno in inaktivirano bakterijskih cepiv - psi - aktivna imunizacija psov od šestega tedna starosti. - če želite preprečiti klinični znaki in zmanjšanje virusne izločanje, povzročeno z udarci parainfluenza virus, da se prepreči kliničnih znakov bolezni, okužbe sečil, izločanje, povzročeno s leptospira serovars bratislava, canicola, grippotyphosa in icterohaemorrhagiae. začetek imunosti: imunski odziv je bil dokazan 3 tedne po zaključku primarnega tečaja za cpiv in 4 tedne po končanem osnovnem tečaju za komponente leptospira. trajanje imunitete: vsaj eno leto po osnovnem cepljenju za vse komponente versican plus pi / l4.

Europese Unie - Sloveens - EMA (European Medicines Agency)

zoetis belgium s.a. - canine parainfluenza virus, leptospira and rabies virus. - immunologicals za canidae, Živo in inaktivirano virusnih in bakterijskih cepiv - psi - aktivni imunizaciji pse iz šestih tednih starosti, da se prepreči klinični znaki in zmanjšanje virusne izločanje vzrok za odvračanje parainfluenza virus, da se prepreči kliničnih znakov bolezni, okužbe sečil, izločanje vzrok za leptospira serovars bratislava, canicola, grippotyphosa in icterohaemorrhagiae in za preprečevanje umrljivosti, klinični znaki in okužba vzrok za virus stekline.

Europese Unie - Sloveens - EMA (European Medicines Agency)

zoetis belgium sa - inaktivirani virus schmallenberg, sev bh80 / 11-4 - immunologicals za bovidae, inaktivirano virusna cepiva - cattle; sheep - za aktivno imunizacijo goveda in ovac od 3. starost 5 mesecev, da preprečijo viremijo, povezano z okužbo z virusom schmallenberg.